SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042533
Filing Date
2019-11-12
Accepted
2019-11-12 07:16:42
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20190930.htm   iXBRL 10-Q 3322813
2 EX-31.1 sage-ex311_8.htm EX-31.1 9359
3 EX-31.2 sage-ex312_9.htm EX-31.2 9295
4 EX-32.1 sage-ex321_7.htm EX-32.1 8664
5 GRAPHIC gpnui3qm5wki000001.jpg GRAPHIC 35399
  Complete submission text file 0001564590-19-042533.txt   10242006

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20190930.xsd EX-101.SCH 56035
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20190930_cal.xml EX-101.CAL 51430
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20190930_def.xml EX-101.DEF 207798
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20190930_lab.xml EX-101.LAB 419920
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20190930_pre.xml EX-101.PRE 345051
13 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20190930_htm.xml XML 2018965
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 191206059
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences